Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 281
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
J Zoo Wildl Med ; 52(1): 241-252, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33827182

RESUMEN

Native to Southeast Asia, the Sunda pangolin (Manis javanica) is critically endangered largely because of poorly regulated wildlife trade, consumptive practices, and use in traditional Chinese medicine. Efforts to rescue and rehabilitate animals confiscated from the illegal trade are complicated by a general lack of knowledge surrounding the normal health and disease processes unique to the species. To provide clinical reference intervals for normal health states of Sunda pangolins, biochemical parameters were determined from rescued individuals in Vietnam that had undergone a 14-day observation period and met a set of criteria for release back into the wild. Blood samples were collected from 42 apparently healthy Sunda pangolins while anesthetized or awake. Packed cell volume (PCV) and total solids (TS) were determined manually, and serum biochemistry values were determined in-house with a benchtop analyzer. Additional biochemical and mineral parameters not included in the primary panel were determined from a subset of 10 pangolins through an external diagnostic laboratory. Overall reference intervals were calculated for PCV and TS (n = 29) and for standard serum biochemistry parameters (n = 42). Females and males demonstrated significant variation with respect to body mass, potassium (K+), and phosphorus, whereas age was a significant source of variation in alkaline phosphatase. Seasonal variation in glucose (GLU), creatinine (CRE), total proteins, sodium, calcium, and K+ was also observed. Comparisons between anesthetized and awake pangolins demonstrated significant variation in GLU, CRE, and K+. The parameters determined in this study can serve as a clinical reference for ex situ Sunda pangolin conservation efforts. In the context of wildlife rehabilitation, serial bloodwork allows for continued monitoring of patient health and should inform decision making regarding release readiness and timing.


Asunto(s)
Minerales/sangre , Pangolines/sangre , Crianza de Animales Domésticos , Animales , Animales Salvajes , Glucemia , Nitrógeno de la Urea Sanguínea , Creatina/sangre , Especies en Peligro de Extinción , Enzimas/sangre , Femenino , Hematócrito , Masculino , Valores de Referencia , Vietnam
2.
Artículo en Inglés | MEDLINE | ID: mdl-33726658

RESUMEN

BACKGROUND: In Covid-19 infection, leukopenia, inflammation, and elevated liver enzymes are found in most patients. Also, vitamin D deficiency attenuates the immune system and predisposes a person to being more susceptible to infection. In this context, we aimed to evaluate vitamin D, electrolytes, complete blood count, liver enzymes, urea, creatinine, albumin, CRP and ESR levels in patients with Covid-19. METHODS: We conducted a cross-sectional study on 118 patients with Covid-19 who were hospitalized from 2020/2/19 to 2020/4/3 in ICU. Serum levels of electrolytes, liver enzymes, blood factors, urea, creatinine, CRP and ESR, as well as anthropometric parameters and serum vitamin D concentration, were measured. RESULTS: A total of 118 patients (80 male and 38 female) were enrolled in the study (65.05±15.75 years). Only 5.08% of patients had no risk factors and 55.9% had ≥ 2 risk factors. Diabetes (44.1%) and obesity (23.7%) were more common among patients. Laboratory findings showed that 80.50% of patients had hyponatremia, but other electrolytes including K, Mg, Ca and P were normal in the majority of participants as well as CBC, Cr, Urea, Alb, ALT and ALKP. The AST concentration increased in most patients (66.94%). All patients had high levels of inflammatory factors such as CRP and ESR. The mean of 25-hydroxy-vitamin D levels in participants (25.95 ± 14.56 ng/mL) was lower than its levels in the general population. However, it was not statistically significant (P= 0.88). A significant negative correlation was found between vitamin D and ALT (P= 0.02, -0.21) as well as vitamin D and CRP (P= 0.05, -0.17). CONCLUSION: Due to the regulatory role of vitamin D in the immune system and low levels of vitamin D in Covid-19 infected patients, the evaluation of vitamin D levels and prescribed supplements, if necessary, is suggested.


Asunto(s)
COVID-19/sangre , Unidades de Cuidados Intensivos , SARS-CoV-2/patogenicidad , Deficiencia de Vitamina D/sangre , Vitamina D/análogos & derivados , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Proteína C-Reactiva/análisis , COVID-19/epidemiología , COVID-19/inmunología , COVID-19/virología , Comorbilidad , Estudios Transversales , Electrólitos/sangre , Enzimas/sangre , Femenino , Interacciones Huésped-Patógeno , Humanos , Irán/epidemiología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Medición de Riesgo , Factores de Riesgo , Vitamina D/sangre , Deficiencia de Vitamina D/epidemiología , Deficiencia de Vitamina D/inmunología
3.
Nutrients ; 13(3)2021 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-33652910

RESUMEN

This study investigated the effect of decaffeinated green tea extract (dGTE), with or without antioxidant nutrients, on fat oxidation, body composition and cardio-metabolic health measures in overweight individuals engaged in regular exercise. Twenty-seven participants (20 females, 7 males; body mass: 77.5 ± 10.5 kg; body mass index: 27.4 ± 3.0 kg·m2; peak oxygen uptake (O2peak): 30.2 ± 5.8 mL·kg-1·min-1) were randomly assigned, in a double-blinded manner, either: dGTE (400 mg·d-1 (-)-epigallocatechin-3-gallate (EGCG), n = 9); a novel dGTE+ (400 mg·d-1 EGCG, quercetin (50 mg·d-1) and α-lipoic acid (LA, 150 mg·d-1), n = 9); or placebo (PL, n = 9) for 8 weeks, whilst maintaining standardised, aerobic exercise. Fat oxidation ('FATMAX' and steady state exercise protocols), body composition, cardio-metabolic and blood measures (serum glucose, insulin, leptin, adiponectin, glycerol, free fatty acids, total cholesterol, high [HDL-c] and low-density lipoprotein cholesterol [LDL-c], triglycerides, liver enzymes and bilirubin) were assessed at baseline, week 4 and 8. Following 8 weeks of dGTE+, maximal fat oxidation (MFO) significantly improved from 154.4 ± 20.6 to 224.6 ± 23.2 mg·min-1 (p = 0.009), along with a 22.5% increase in the exercise intensity at which fat oxidation was deemed negligible (FATMIN; 67.6 ± 3.6%O2peak, p = 0.003). Steady state exercise substrate utilisation also improved for dGTE+ only, with respiratory exchange ratio reducing from 0.94 ± 0.01 at week 4, to 0.89 ± 0.01 at week 8 (p = 0.004). This corresponded with a significant increase in the contribution of fat to energy expenditure for dGTE+ from 21.0 ± 4.1% at week 4, to 34.6 ± 4.7% at week 8 (p = 0.006). LDL-c was also lower (normalised fold change of -0.09 ± 0.06) for dGTE+ by week 8 (p = 0.038). No other significant effects were found in any group. Eight weeks of dGTE+ improved MFO and substrate utilisation during exercise, and lowered LDL-c. However, body composition and cardio-metabolic markers in healthy, overweight individuals who maintained regular physical activity were largely unaffected by dGTE.


Asunto(s)
Tejido Adiposo/efectos de los fármacos , Antioxidantes/administración & dosificación , Sobrepeso/terapia , Extractos Vegetales/administración & dosificación , , Adiponectina/sangre , Adulto , Bilirrubina/sangre , Glucemia/efectos de los fármacos , Composición Corporal/efectos de los fármacos , Índice de Masa Corporal , Factores de Riesgo Cardiometabólico , Colesterol/sangre , Método Doble Ciego , Metabolismo Energético/efectos de los fármacos , Enzimas/sangre , Ejercicio Físico/fisiología , Ácidos Grasos no Esterificados/sangre , Femenino , Glicerol/sangre , Humanos , Insulina/sangre , Leptina/sangre , Masculino , Persona de Mediana Edad , Sobrepeso/fisiopatología , Oxidación-Reducción/efectos de los fármacos , Consumo de Oxígeno/efectos de los fármacos
4.
J Ethnopharmacol ; 267: 113508, 2021 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-33169693

RESUMEN

Influence of quail egg on pathologies has increased research interests and series of investigations are currently being done on its influence against these pathologies. The influence of quail egg against 2-butoxyethanol induced hemolysis and disseminated thrombosis was investigated to determine the enzymatic regulations that ensue in the amelioration of deleterious hemolytic and disseminated thrombosis displayed in female Wistar rats. Quail egg was separated into three (3) components (extracts)-quail egg yolk water soluble (QYWS) and fat soluble (QYFS), and albumen extract (QA) and the inorganic and organic compositions were characterized. Depranocytotic assaults was achieved by 250 mg/kg of 2-Butoxyethanol administered for 4 days, the clinical observation revealed a dark purple-red discoloration on the distal tails of the rats and therapeutic applications followed with 1000 mg/kg BWT of QYWS, QYFS and QA, and 15 mg/kg BWT of hydroxyurea. Morphological evaluation, haematological estimations and biochemical evaluations of the influence on the activities of sphingosine kinase-1, RNase, red cell carbonic anhydrase, lactate dehydrogenase, glutathione peroxidase and caspase-3, vis a vis the concentrations of sphingosine-1 phosphate, selenium and zinc (plasma and urine). In vitro anti-inflammatory influence of quail egg components were investigated against hemolysis and key enzymes of inflammation-cycloxygenase, lipoxygenase and ß-glucuronidase. The in vitro anti-inflammatory effects of QYWS, QYFS and QA were concentration dependent from 200 to 800 µg/ml against hemolysis and the key enzymes of inflammation. The characterization of inorganic and organic bioactive composition of the yolk and albumen revealed the presence of folic acid, cobalamin, pyridine, riboflavin, ascorbic acid as well as vitamins D and E, selenium, zinc, iron and calcium. These had reflected in the attenuation of the induced hemolytic and disseminated thrombosis by regulations of enzymes linked to the infarction, apoptosis and oxidative stress characterized in sickle cell index.


Asunto(s)
Anemia de Células Falciformes/prevención & control , Antidrepanocíticos/farmacología , Extractos Celulares/farmacología , Coturnix , Huevos , Enzimas/sangre , Eritrocitos/efectos de los fármacos , Glicoles de Etileno , Hemólisis/efectos de los fármacos , Trombosis/prevención & control , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/inducido químicamente , Anemia de Células Falciformes/enzimología , Animales , Antiinflamatorios/farmacología , Antioxidantes/farmacología , Antidrepanocíticos/aislamiento & purificación , Apoptosis/efectos de los fármacos , Extractos Celulares/aislamiento & purificación , Modelos Animales de Enfermedad , Eritrocitos/enzimología , Eritrocitos/patología , Femenino , Fibrinolíticos/farmacología , Mediadores de Inflamación/metabolismo , Estrés Oxidativo , Ratas Wistar , Trombosis/sangre , Trombosis/inducido químicamente , Trombosis/enzimología
5.
Pharm Biol ; 58(1): 1156-1166, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33222562

RESUMEN

CONTEXT: The Traditional Chinese herb medicine Dalbergia odorifera T. Chen (Fabaceae), exerted a protective effect on myocardial ischaemia. Latifolin is a neoflavonoid extracted from Dalbergia odorifera. It has been reported to have the effects of anti-inflammation and cardiomyocyte protection. OBJECTIVE: To investigate whether latifolin can improve myocardial infarction (MI) through attenuating myocardial inflammatory and to explore its possible mechanisms. MATERIALS AND METHODS: Left coronary artery was ligated to induce a rat model of MI, and the rats were treated with sodium carboxymethyl cellulose (CMC-Na) or different doses of latifolin (25, 50, 100 mg/kg/d) by oral gavage for 28 days. Serum contents of myocardial enzyme were measured at seven and fourteen days after treatment. Cardiac function, infarct size, histopathological changes and inflammatory cells infiltration was assessed at 28 days after treatment. Western blotting was used to investigate the underlying mechanisms. RESULTS: Latifolin treatment markedly decreased the contents of myocardial enzymes, and increased left ventricular ejection fraction (85.27% vs. 59.11%) and left ventricular fractional shortening (62.71% vs. 45.53%). Latifolin was found to significantly reduced infarction size (27.78% vs. 39.07%), myocardial fibrosis and the numbers of macrophage infiltration (436 cells/mm2 vs. 690 cells/mm2). In addition, latifolin down-regulated the expression levels of hypoxia-inducible factor-1α (0.95-fold), phospho-nuclear factor-κB (0.2-fold) and interleukin-6 (1.11-fold). DISCUSSION AND CONCLUSIONS: Latifolin can protect against myocardial infarction by improving myocardial inflammation through the HIF-1α/NF-κB/IL-6 signalling pathway. Accordingly, latifolin may be a promising drug for pharmacological treatment of ischaemic cardiovascular disease.


Asunto(s)
Subunidad alfa del Factor 1 Inducible por Hipoxia/efectos de los fármacos , Interleucina-6 , Infarto del Miocardio/prevención & control , Miocarditis/tratamiento farmacológico , FN-kappa B/efectos de los fármacos , Fenoles/uso terapéutico , Transducción de Señal/efectos de los fármacos , Animales , Dalbergia/química , Enzimas/sangre , Pruebas de Función Cardíaca , Masculino , Medicina Tradicional China , Infarto del Miocardio/patología , Miocarditis/patología , Miocardio/patología , Ratas , Ratas Sprague-Dawley , Volumen Sistólico
6.
Mar Drugs ; 18(8)2020 Aug 02.
Artículo en Inglés | MEDLINE | ID: mdl-32748864

RESUMEN

Chitosan oligosaccharide is known to ameliorate hypercholesterolemia and diabetes. However, some studies found that chitosan oligosaccharide might induce mild to moderate hepatic damage in high-fat (HF) diet-induced obese rats or diabetic rats. Chitosan oligosaccharide can be as a dietary supplement, functional food, or drug. Its possible toxic effects to normal subjects need to be clarified. This study is designed to investigate the effects of chitosan oligosaccharide on plasma and hepatic lipid metabolism and liver histomorphology in normal Sprague-Dawley rats. Diets supplemented with 5% chitosan oligosaccharide have been found to induce liver damage in HF diet-fed rats. We therefore selected 5% chitosan oligosaccharide as an experimental object. Rats were divided into: a normal control diet group and a normal control diet +5% chitosan oligosaccharide group. The experimental period was 12 weeks. The results showed that supplementation of 5% chitosan oligosaccharide did not significantly change the body weight, food intake, liver/adipose tissue weights, plasma lipids, hepatic lipids, plasma levels of AST, ALT, and TNF-α/IL-6, hepatic lipid peroxidation and anti-oxidative enzyme activities, fecal lipids, and liver histomorphology in normal rats. These findings suggest that supplementation of 5% chitosan oligosaccharide for 12 weeks may not induce lipid metabolism disorder and liver toxicity in normal rats.


Asunto(s)
Quitina/análogos & derivados , Suplementos Dietéticos , Hígado/efectos de los fármacos , Animales , Biomarcadores/sangre , Quitina/farmacología , Quitosano , Enzimas/sangre , Mediadores de Inflamación/sangre , Lípidos/sangre , Hígado/metabolismo , Oligosacáridos , Ratas Sprague-Dawley , Factores de Tiempo
7.
Nutrients ; 12(4)2020 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-32283716

RESUMEN

Oligosaccharides are complex, non-digestible glycans found in large abundance in human milk. The abundance and the profile of bovine milk oligosaccharides and bovine milk based in infant formula differ from those in human milk. Recently, some human milk oligosaccharides (HMOs) have been supplemented to infant formula, however, not all forms have been available in large scale. The objective of the study was to investigate the dose-dependent effects of an enzymatically-synthesized 6'-sialyllactose (6'-SL) sodium salt supplemented to swine milk replacer on growth, hematological parameters, and organ microscopic assessment in our pre-clinical neonatal pig model. Two-day-old male and female pigs (n = 47) were provided one of four experimental diets for 21 days. Diets were formulated to contain 0 (CON), 300 (LOW), 600 (MOD), or 1200 (HIGH) mg/L of 6'-SL sodium salt. On days 8 and 22, samples were collected for hematological and histological analyses. Supplemental 6'-SL sodium salt at all doses supported growth and development comparable to those observed in control animals. In addition, serum chemistries, hematology, and organ microscopic structure were unaffected by 6'-SL (p > 0.05). Thus, addition of enzymatically-synthesized 6'-SL to a milk replacer formula supported growth and clinical outcomes similar to the control formula in the neonatal piglet.


Asunto(s)
Alimentación Animal , Fenómenos Fisiológicos Nutricionales de los Animales/fisiología , Animales Recién Nacidos/crecimiento & desarrollo , Dieta/veterinaria , Suplementos Dietéticos , Lactosa/análogos & derivados , Leche , Porcinos/crecimiento & desarrollo , Animales , Animales Recién Nacidos/sangre , Análisis Químico de la Sangre , Proteínas Sanguíneas/análisis , Enzimas/sangre , Femenino , Pruebas Hematológicas , Lactosa/administración & dosificación , Lactosa/síntesis química , Masculino , Minerales/sangre , Porcinos/sangre , Tiempo de Coagulación de la Sangre Total
8.
Pak J Pharm Sci ; 33(5(Special)): 2449-2454, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33832889

RESUMEN

Ziziphus oxyphylla Edgew (Z. oxyphylla) is a small shrub to a medium sized tree. The aim of the present study was to evaluate the hepatoprotective activity of Z. oxyphylla in paracetamol-induced hepatotoxic rat model. Silymarin was used as a standard drug. Methanol extract was found to be the most potent in in-vitro antioxidant studies. The methanol extract of Z. oxyphylla was administered to experimental animals. The hepatoprotective effect of extract was evaluated by measuring liver biochemical markers, anti-oxidant enzymes and blood lipid profile. Treatment with the paracetamol increased the level of hepatic biomarkers, blood lipid profile and decreased anti-oxidant enzymes. Pre-treatment with Z. oxyphylla caused restoration of hepatic biomarkers, blood lipid profile and antioxidant enzymes levels. It is concluded that the methanol extract of Z. oxyphylla possesses hepatoprotective activity that might be due to quercetin and kaempferol glycosides present in the plant extract. Further studies are required to elucidate the exact mechanism of action of these isolated flavonoid glycosides.


Asunto(s)
Antioxidantes/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Ziziphus , Acetaminofén , Animales , Antioxidantes/aislamiento & purificación , Biomarcadores/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Modelos Animales de Enfermedad , Enzimas/sangre , Lípidos/sangre , Hígado/metabolismo , Hígado/patología , Masculino , Metanol/química , Extractos Vegetales/aislamiento & purificación , Hojas de la Planta , Ratas Wistar , Solventes/química , Ziziphus/química
9.
Nat Prod Res ; 34(22): 3226-3230, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30663351

RESUMEN

The authors studied the effect of hot pepper (capsicum sp.) oil on the growth performance and blood parameters in rainbow trout fed. Hot pepper oil was added to rainbow trout feeds at the rates of HPO 0‰ (0 mg/kg) (control), HPO 1‰ (1 mg/kg), HPO 2‰ (2 mg/kg), HPO 4‰ (4 mg/kg) and HPO 6‰ (6 mg/kg), and the fish were fed with experimental feeds for 60 days. The group fed with HPO 4‰ showed the highest percentage growth rate and the lowest feed conversion rate. Our results showed the significant differences serum biochemical parameters, a decrease of serum liver enzymes, glucose, cholesterol and triglyceride levels and an increase of total protein and albumin levels compared with the control. The use of HPO 1‰ in rainbow trout showed a positively affects the growth performance, haematological and serum biochemical parameters.[Formula: see text].


Asunto(s)
Alimentación Animal , Capsicum/química , Oncorhynchus mykiss/sangre , Oncorhynchus mykiss/crecimiento & desarrollo , Aceites de Plantas/farmacología , Animales , Acuicultura , Colesterol/sangre , Enzimas/sangre , Aceites Volátiles/análisis , Triglicéridos/sangre
10.
Anim Biotechnol ; 31(6): 483-490, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31230524

RESUMEN

A total of 270 one-d-old Ross 308 broiler chicks were randomly allotted to 9 experimental diets (3 replicates of 10 birds each), including three types of supplemental lipotropic factors (control, 0.1% or 0.2% choline and 0.5% or 1% lecithin) in a 3 × 3 factorial arrangement. Supplementation of lecithin improved FCR values during 1-21 days of age. Although no differences were noticed for mortality index among different diets, the group supplemented with a combination of choline (0.1) and lecithin (0.5) showed the highest (P < 0.0001) production index. Choline (0.1% or 0.2%) significantly decreased serum total cholesterol by 11%, triglycerides by 21%, low-density lipoprotein (LDL) by 20%, and very low-density lipoprotein (VLDL) by 20%, while increased the glucose and high-density lipoprotein (HDL) values by 11% and 6%, respectively. On the other hand, lecithin significantly increased glucose, total cholesterol, triglycerides, HDL, LDL and VLDL by 4%, 9%, 7%, 24%, and 25%, respectively. Choline supplementation decreased the aspartate amino transferase (AST), alanine amino transferase (ALT), and alkaline phosphatase (AP); however, the lecithin addition increased their respective proportions. This study concluded that the combinations of 0.1% choline and 0.5% lecithin is the best among all other treatments because of the highest production index and least mortality.


Asunto(s)
Grasa Abdominal/efectos de los fármacos , Alimentación Animal , Pollos , Colina , Lecitinas , Animales , Pollos/crecimiento & desarrollo , Pollos/fisiología , Colesterol/sangre , Colina/administración & dosificación , Colina/farmacología , Dieta/veterinaria , Enzimas/sangre , Lecitinas/administración & dosificación , Lecitinas/farmacología , Masculino , Estrés Fisiológico/efectos de los fármacos
11.
Biomed Res Int ; 2019: 6289380, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31275980

RESUMEN

Early recovery from muscular injury is crucial for elite athletes. Hyperbaric oxygen therapy (HBOT) has been reported to be beneficial in terms of accelerating cell recovery and tissue repair, which are considered to be helpful for eliminating fatigue and recovering stamina. This study was performed to evaluate the efficacy of HBOT for exercise-related muscular injury. Forty-one athletes with exercise-related muscular injuries were recruited and randomized into an HBOT group and a control group. All participants received 10 sessions of either HBOT or placebo treatment. The brief pain inventory (BPI) was completed, and serum samples were analyzed. Data were collected before treatment (T1), at the end of the fifth treatment session (T2), at the end of the tenth treatment session (T3), and two weeks after T3 (T4). At T3, the HBOT group showed prominent reductions in the levels of creatine phosphokinase (CK), glutamic oxaloacetate transaminase (GOT), and myoglobin (MB), which lasted until T4. However, the control group did not present any statistical differences in levels from T1 to T4. In terms of pain intensity and interference, the HBOT group showed significant improvements at T3, while no improvements were observed in the control group. In conclusion, HBOT facilitates the early recovery of exercise-related muscular injury. This trial is registered with ISRCTN17817041.


Asunto(s)
Ejercicio Físico/fisiología , Oxigenoterapia Hiperbárica , Músculos/lesiones , Adulto , Enzimas/sangre , Humanos , Masculino , Músculos/enzimología , Dolor/patología , Dimensión del Dolor , Resultado del Tratamiento , Adulto Joven
12.
J Nutr Biochem ; 68: 33-41, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-31030165

RESUMEN

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic hepatic injury in the world. One of the most important therapeutic strategies for this disease is modulating oxidative stress. This study hypothesized that supplementation of pinitol might exert hepatic protective effects, by modulating oxidative stress in subjects with NAFLD. A randomized, double-blind controlled trial was conducted in 90 subjects with ultrasonography-proven NAFLD, who were randomly assigned to the placebo, low-dose (300 mg/d), or high-dose (500 mg/d) of pinitol for 12 weeks. The outcome measures were liver fat content, liver enzymes, fasting and postprandial lipids, and oxidative stress levels. To understand the underlying mechanism, plasma metabolomic analysis based on a gas chromatography/time-of-flight mass spectrometry and urinary pinitol analysis were also performed. The pinitol group showed significantly lower levels in liver fat content, plasma liver enzymes, fasting/postprandial urinary malondialdehyde levels, and postprandial triglycerides concentrations, but significantly higher in glutathione peroxidase level compared with the placebo group. The metabolomic analysis identified 27 differential metabolites involved in glycine/serine/threonine metabolism, alanine/aspartate/glutamate metabolism, D-glutamine/D-glutamate metabolism, and fatty acid synthesis, implicating the role of pinitol in glutathione-related lipid and energy metabolism. These results suggest that pinitol may exert modulatory effects upon energy and metabolic pathways by reducing oxidative stress and fatty acid accumulation, which can lead to hepatoprotective benefits in NAFLD subjects.


Asunto(s)
Inositol/análogos & derivados , Hígado/efectos de los fármacos , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Suplementos Dietéticos , Método Doble Ciego , Enzimas/sangre , Ácidos Grasos/metabolismo , Femenino , Humanos , Inositol/farmacología , Lípidos/sangre , Hígado/metabolismo , Masculino , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/diagnóstico por imagen , Estrés Oxidativo/efectos de los fármacos , Periodo Posprandial
13.
Biomed Pharmacother ; 106: 1317-1324, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30119202

RESUMEN

BACKGROUND: This study aimed to investigate and characterize the anti-inflammatory and anti-hypernociceptive effects of the total polysaccharides of X. americana (TPL-Xa) bark in a mouse model of acute pancreatitis-induced by caerulein and the potential involvement of cannabinoid receptors. METHODS: TPL-Xa was characterized by1H and 13C NMR spectroscopy. Animals received TPL-Xa (10 mg/kg, i.v.) 30 min before and after caerulein (50 µg/kg, 10×, i.p.) administration. To evaluate the involvement of cannabinoid receptors, AM281 (3 mg/kg, s.c.) and AM630 (1 mg/kg, s.c.) were administered 30 min before TPL-Xa. Plasma levels of amylase and lipase, pancreatic myeloperoxidase (MPO), histology, visceral hypernociception and motor coordination were evaluated 11 and 24 h after acute pancreatitis (AP) induction. RESULTS: TPL-Xa, containing a heteropolysaccharide composed of glucose, galactose, arabinose, rhamnose, fucose and galacturonic acid, reduced amylase and lipase levels, MPO activity, acinar cell necrosis, edema and neutrophil infiltration. TPL-Xa increased the threshold of visceral hypernociception, an effect reversed by AM630, an antagonist of cannabinoid receptor type 2 (CB2). In addition, TPL-Xa did not alter the animals' motor coordination. CONCLUSIONS: TPL-Xa contains heteropolysaccharides that inhibit inflammation and hypernociception in the experimental model of caerulein-induced AP, by a mechanism involving type CB2 receptors.


Asunto(s)
Analgésicos/farmacología , Antiinflamatorios/farmacología , Agonistas de Receptores de Cannabinoides/farmacología , Ceruletida , Dolor Nociceptivo/prevención & control , Olacaceae , Páncreas/efectos de los fármacos , Pancreatitis/prevención & control , Extractos Vegetales/farmacología , Polisacáridos/farmacología , Receptor Cannabinoide CB2/agonistas , Analgésicos/aislamiento & purificación , Animales , Antiinflamatorios/aislamiento & purificación , Agonistas de Receptores de Cannabinoides/aislamiento & purificación , Espectroscopía de Resonancia Magnética con Carbono-13 , Modelos Animales de Enfermedad , Enzimas/sangre , Mediadores de Inflamación/metabolismo , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Dolor Nociceptivo/inducido químicamente , Dolor Nociceptivo/metabolismo , Olacaceae/química , Umbral del Dolor/efectos de los fármacos , Páncreas/enzimología , Páncreas/patología , Pancreatitis/inducido químicamente , Pancreatitis/metabolismo , Pancreatitis/patología , Fitoterapia , Extractos Vegetales/aislamiento & purificación , Plantas Medicinales , Polisacáridos/aislamiento & purificación , Espectroscopía de Protones por Resonancia Magnética , Receptor Cannabinoide CB2/metabolismo , Transducción de Señal/efectos de los fármacos , Factores de Tiempo
14.
Biomed Pharmacother ; 106: 785-793, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29990872

RESUMEN

Ischemia-reperfusion (I/R) injury is a pathological process which magnifies with the ensuing inflammatory response and endures with the increase of oxidants especially during reperfusion. The present study was conducted to assess the possible modulatory effects of plumbagin, the active constituent extracted from the roots of traditional medicinal plant Plumbago zeylanica L., on the dire role of high mobility group box 1 (HMGB1) as well as the associated inflammation, oxidative stress and apoptotic cell death following hepatic I/R. Four groups of rats were included: sham-operated, sham-operated treated with plumbagin, I/R (30 min ischemia and 1 h reperfusion) and I/R treated with plumbagin. Pretreatment with plumbagin markedly improved hepatic function and structural integrity compared to the I/R group, as manifested by depressed plasma transaminases and lactate dehydrogenase (LDH) activities as well as alleviated tissue pathological lesions. Plumbagin prominently hampered HMGB1 expression and subsequently quelled inflammatory cascades, as nuclear factor κB (NF-κB), tumor necrosis factor-alpha (TNF-α) and myeloperoxidase (MPO) activity. It also interrupted reactive oxygen species (ROS)-HMGB1loop as evident by restored liver reduced glutathione (GSH), elevated glutathione peroxidase (GPx) activity, along with decreased liver lipid peroxidation. Simultaneously, plumbagin significantly ameliorated apoptosis by amending the mRNA expressions of both anti-apoptotic (Bcl-2) and pro-apoptotic (Bax). The present results revealed that plumbagin is endowed with hepatoprotective activity ascribed to its antioxidant, anti-inflammatory and anti-apoptotic properties which are partially mediated through dampening of HMGB1 expression.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Proteína HMGB1/metabolismo , Hepatitis/prevención & control , Hígado/efectos de los fármacos , Naftoquinonas/farmacología , Estrés Oxidativo/efectos de los fármacos , Daño por Reperfusión/prevención & control , Animales , Biomarcadores/sangre , Citoprotección , Modelos Animales de Enfermedad , Enzimas/sangre , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Hepatitis/metabolismo , Hepatitis/patología , Mediadores de Inflamación/sangre , Peroxidación de Lípido/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Transducción de Señal/efectos de los fármacos
15.
Environ Sci Pollut Res Int ; 25(24): 23897-23908, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29881964

RESUMEN

In the current study, the possible prophylactic and therapeutic effects of colostrum (COL) on acute organ injury caused by paracetamol (PAR) in rats were evaluated. Within the scope of this study, a 2-month-old male (150-200 g) 70 Wistar Albino rat was used and a total of seven groups were designed. The first group (CNT) was maintained for control purposes. The second group (COL-1) was given COL for 1 day, at a dose of 500 mg/kg at 6-h intervals, and blood and tissue sampling was performed at 24 h. The third group (COL-7) received COL for 7 days, at a dose of 500 mg/kg at 6-h intervals on day 1 and at a daily dose of 500 mg/kg on the following days, and blood and tissue samples were taken at the end of seventh day. The fourth group (PAR-1) was administered with PAR at a dose of 1.0 g/kg bw and was blood and tissue sampled at 24 h. The fifth group (PAR-7) received PAR at a dose of 1.0 g/kg bw on day 1 and was blood and tissue was removed at the end of day 7. The sixth group (PAR+COL-1) was administered with a combination of PAR (1 g/kg bw) and COL (500 mg/kg at 6-h intervals), and blood and tissue samples were collected at 24 h. The seventh group (PAR+COL-7) received 1.0 g/kg bw of PAR on day 1 and was given COL throughout the 7-day study period (at a dose of 500 mg/kg at 6-h intervals on day 1 and at a daily dose of 500 mg/kg on the following days). In the seventh group, blood and tissue samples were taken at the end of seventh day. Alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), glucose, creatinine, triglyceride, total bilirubin, total protein and albumin levels/activities were analysed in the serum samples. The malondialdehyde (MDA), nitric oxide (NO), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) levels/activities, known as oxidative stress parameters, were assayed for tissue homogenates and blood (erythrocytes/plasma); in addition, enzyme activities of GSH S-transferase (GST), cytochrome P4502E1 (CYP2E1), NADH-cytochrome b5 reductase (CYTB5), glucose-6-phosphate dehydrogenase (G6PD), NADPH-cytochrome P450 C reductase (CYTC) and glutathione (GSH) levels/activities defined as drug metabolising parameters were measured in liver homogenates. In result, it was determined that PAR caused significant alterations in some biochemical and lipid peroxidation parameters and the activities/levels of drug metabolising parameters in the liver and that COL normalised some of these parameters and reduced PAR-induced tissue damage.


Asunto(s)
Acetaminofén/toxicidad , Calostro , Animales , Nitrógeno de la Urea Sanguínea , Enzimas/sangre , Femenino , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Malondialdehído/metabolismo , Óxido Nítrico/metabolismo , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Triglicéridos/sangre
16.
Arch Environ Contam Toxicol ; 75(1): 37-44, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29737374

RESUMEN

Selenium (Se) is an essential nutrient which in excess causes toxicity. The disposal of incompletely combusted coal, which often is rich in Se, into aquatic settling basins is increasing the risk of Se exposure worldwide. However, very few studies have looked at the physiological effects of Se exposure on long-lived, top trophic vertebrates, such as the American alligator (Alligator mississippiensis). During a 7-week period, alligators were fed one of three dietary treatments: mice injected with deionized water or mice injected with water containing 1000 or 2000 ppm selenomethionine (SeMet). One week after the last feeding alligators were bled within 3 min of capture for plasma corticosterone (CORT). A few days later, all alligators were euthanized and whole blood and tail tissue were harvested to measure oxidative damage, an antioxidant-associated transcription factor, and antioxidant enzymes [glutathione peroxidase-1 (GPX1), superoxide dismutase-1 (SOD1), and SOD2] by Western blotting. There was a dose-dependent increase in baseline CORT levels in alligators administered SeMet. Except for blood SOD2 levels, SeMet treatment had no effect (p > 0.05 for all) on oxidative status: oxidative damage, GPX1, SOD1, and muscle SOD2 levels were similar among treatments. Our results illustrate that high levels of Se may act as a stressor to crocodilians. Future studies should investigate further the physiological effects of Se accumulation in long-lived, top-trophic vertebrates.


Asunto(s)
Caimanes y Cocodrilos/sangre , Exposición Dietética/efectos adversos , Enzimas/análisis , Selenometionina/toxicidad , Aldehídos/análisis , Animales , Antioxidantes/análisis , Carbón Mineral , Corticosterona , Enzimas/sangre , Glutatión Peroxidasa/análisis , Ratones , Estrés Oxidativo/efectos de los fármacos , Selenio/farmacocinética , Selenometionina/administración & dosificación , Cola (estructura animal)/química , Glutatión Peroxidasa GPX1
17.
Ann Hepatol ; 17(3): 482-489, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29735797

RESUMEN

INTRODUCTION AND AIM: Aegle marmelos is an important traditional herbal medicine used in India. The dietary inclusion of the plant has never exposed earlier for its hepatoprotective activity. This study aimed to investigate the modulator efficacy of dietary inclusion of Aegle marmelos against Cisplatin - induced hepatotoxicity in Wistar albino rats. MATERIAL AND METHODS: Animals were divided into five different groups; Group I was given basal diets only, Group II was fed basal diets with Aegle marmelos in 4% concentration, while Group III was fed basal diets co-administered with Cisplatin. Group IV and V were administered diets containing 2 and 4% Aegle marmelos respectively, for 27 days prior to Cisplatin administration. Cisplatin was administered to the rats for 3 days leads to a reduction in the activities of the antioxidant enzymes like lipid peroxidation (LPO) and endogenous antioxidant systems such as reduced superoxide dismutase (SOD), glutathione (GSH) and catalase in liver homogenate caused to produce the impairment of hepatic functions. RESULTS: The administration of fruit part of Aegle marmelos to Wistar rats showed a significant fall in the elevated Lipid peroxidation, superoxide dismutase, glutathione and catalase concentration, moreover, it diminished the increased serum level of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), acid phosphatase (ACP) and bilirubin. CONCLUSIONS: We can conclude that the hepatoprotective activity of Aegle marmelos was due to its antioxidant effect as evidenced by increasing activity of antioxidant enzymes with enhanced hepatic function and significantly changed the physiological parameters.


Asunto(s)
Aegle , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Cisplatino , Dieta , Frutas , Hígado , Alimentación Animal , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Antioxidantes/metabolismo , Bilirrubina/sangre , Biomarcadores/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Modelos Animales de Enfermedad , Enzimas/sangre , Peroxidación de Lípido , Hígado/enzimología , Hígado/patología , Estrés Oxidativo , Ratas Wistar
18.
Chem Biol Interact ; 286: 78-87, 2018 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-29548727

RESUMEN

Chelation therapy is the mainstream treatment for heavy metal poisoning. Apart from this, therapy using antioxidant/herbal extracts are the other strategies now commonly being tried for the treatment. We have previously reported individual beneficial efficacy of nanoparticle mediated administration of an antioxidant like 'curcumin' and an arsenic chelator 'monoisoamyl 2,3-dimercaptosuccinic acid (MiADMSA)' for the treatment of arsenic toxicity compared to bulk drugs. The present paper investigates our hypothesis that a combination drug delivery therapy employing two nanosystems, a chelator and a strong antioxidant, may produce more pronounced therapeutic effects compared to individual effects in the treatment of arsenic toxicity. An in-vivo study was conducted wherein arsenic as sodium arsenite (100 ppm) was administered in drinking water for 5 months to Swiss albino mice. This was followed by a treatment protocol comprising of curcumin encapsulated chitosan nanoparticles (nano-curcumin, 15 mg/kg, orally for 1 month) either alone or in combination with MiADMSA encapsulated polymeric nanoparticles (nano-MiADMSA, 50 mg/kg for last 5 days) to evaluate the therapeutic potential of the combination treatment. Our results demonstrated that co-treatment with nano-curcumin and nano-MiADMSA provided beneficial effects in a synergistic way on the adverse changes in oxidative stress parameters and metal status induced by arsenic.


Asunto(s)
Intoxicación por Arsénico/tratamiento farmacológico , Arsénico/toxicidad , Curcumina/administración & dosificación , Portadores de Fármacos/química , Nanopartículas/química , Succímero/análogos & derivados , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Curcumina/química , Curcumina/farmacología , Desoxiguanosina/análogos & derivados , Desoxiguanosina/orina , Sinergismo Farmacológico , Enzimas/sangre , Enzimas/metabolismo , Enzimas/orina , Glutatión/sangre , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Ratones , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Succímero/administración & dosificación , Succímero/química , Succímero/farmacología
19.
Cell Mol Biol (Noisy-le-grand) ; 64(1): 47-51, 2018 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-29412793

RESUMEN

Citrus Limon Oil (CLO) is known as antioxidant resource and contains limonoids, flavonoids and phenolic compounds. This study was conducted to investigate the effects of different levels of CLO on blood parameters and antioxidant status in Afshari ewes. Six adults Afshari ewes (3-4 years old and 51±5 kg) were randomly allocated to 3×3 Latin square design with three diets in 21 days period. Dietary treatments included:1) control diet, 2) control diet with 200 mg/day CLO, and 3) control diet with 400 mg/day CLO. To evaluate the antioxidant effect of the CLO, sustainable elimination of free radicals by DPPH and ABTS methods were used. The antioxidant activity of essential oils in DPPH method at doses of 32.5, 45, 130, 260 and 520 mg/ml were 9, 16, 31, 49 and 89%, respectively. Also, antioxidant activity of essential oils in ABTS method at doses of 32.5, 45, 130, 260 and 520 mg/ml were 49, 73, 81, 89 and 95%, respectively. CLO treatments did not affect glucose, blood urea nitrogen, albumin, total protein, low density lipoprotein, while improved the concentration of high-density lipoprotein (P>0.01). Results showed that supplementation with CLO significantly decreased (P<0.01) cholesterol, triglycerides and very low density lipoprotein concentrations compared with control. There was no significant difference in analyzed blood bio-chemicals and serum enzymes level between different antioxidant activity methods and groups, suggesting general well-being of ewes. These results suggest that, CLO supplementation had a positive impact on blood traits and antioxidant status of the Afshari ewes.


Asunto(s)
Antioxidantes/farmacología , Citrus , Aceites Volátiles/farmacología , Aceites de Plantas/farmacología , Ovinos/sangre , Animales , Enzimas/sangre , Femenino , Lípidos/sangre
20.
J Anim Physiol Anim Nutr (Berl) ; 102(1): 142-151, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28447361

RESUMEN

The impact of dietary supplementation with microalgae on goat's milk chemical composition, fatty acids (FA) profile and enzymes activities related to antioxidant mechanism has not been well documented. Thus, this study aimed to investigate the effects of dietary inclusion of Chlorella vulgaris on the following: (i) milk yield, chemical composition and FA profile, (ii) the activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione transferase (GST) and glutathione peroxidase (GSH-Px) in blood plasma and (iii) the activities of SOD, GR and lactoperoxidase (LPO) in milk of goats. Furthermore, the oxidative stress indicators for measuring total antioxidant and free radical scavenging activity [ferric reducing ability of plasma (FRAP) and 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assays] and oxidative stress biomarkers [malondialdehyde (MDA) and protein carbonyls (PC)] were also determined in blood plasma and milk of the animals. For this purpose, 16 cross-bred goats were divided into two homogenous groups. Each goat of both groups was fed individually with alfalfa hay and concentrates separately. The concentrates of the control group (Control) had no microalgae, while those of the Chlorella group were supplemented with 10 g lyophilized Chlorella vulgaris/kg concentrates (Chlorella). Thus, the average intake was 5.15 g Chlorella vulgaris/kg DM. The results showed that the dietary inclusion of Chlorella vulgaris had not noticeable impact on goat's milk yield, chemical composition and FA profile. Significantly higher SOD (by 10.31%) and CAT (by 18.66%) activities in the blood plasma of goats fed with Chlorella vulgaris compared with the control were found. Moreover, the dietary supplementation with Chlorella vulgaris caused a significant increase in SOD (by 68.84%) activity and a reduction in PC (by 24.07%) content in goat's milk. In conclusion, the Chlorella vulgaris inclusion in goat's diets improved the antioxidant status of both animals and milk.


Asunto(s)
Alimentación Animal/análisis , Chlorella vulgaris , Dieta/veterinaria , Cabras/fisiología , Leche/enzimología , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Antioxidantes , Biomarcadores , Suplementos Dietéticos , Enzimas/sangre , Enzimas/metabolismo , Ácidos Grasos/química , Femenino , Lactancia , Peroxidación de Lípido , Oxidación-Reducción , Estrés Oxidativo , Carbonilación Proteica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA